The depth and breadth of
With additional animal and human plasma studies expected to drive a better understanding into the mechanism of action (MOA) and new indications, it's beginning to look like a compelling package, notes the broker.
The analyst is buoyed by recent events, including information on new indications and preliminary feedback from the two major regulatory authorities, and a FDA fast-track submission. The target price increases to
Sector: Pharmaceuticals, Biotechnology & Life Sciences.
Target price is
© 2021 Acquisdata Pty Ltd., source